These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 1233521)
41. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial. Akhondzadeh S; Safarcherati A; Amini H Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232 [TBL] [Abstract][Full Text] [Related]
42. [Neurotic inhibition and transnosographic approach. Apropos of a multicenter study of carpipramine]. Ferreri M; Alby JM Encephale; 1987; 13(6):357-65. PubMed ID: 2897281 [TBL] [Abstract][Full Text] [Related]
43. [Noveril treatment of patients with treatment-resistant depressions (comparative evaluation of technics of intravenous drip administration)]. Panteleeva GP; Borisova KE; Mikhaĭlova NM Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(8):1221-6. PubMed ID: 6149662 [TBL] [Abstract][Full Text] [Related]
44. Clozapine--a potential antipsychotic agent without extrapyramidal manifestations. Matz R; Rick W; Thompson H; Gershon S Curr Ther Res Clin Exp; 1974 Jul; 16(7):687-95. PubMed ID: 4210458 [No Abstract] [Full Text] [Related]
46. [Preliminary results of a controlled trial with sulpiride versus chlorimipramine in chronic schizophrenic patients with marked ideo-emotional poverty (author's transl)]. Masciocchi A; Reitano S; Vanini M; Cicchetti V Riv Patol Nerv Ment; 1974 Jan; 95(1):47-52. PubMed ID: 4421825 [No Abstract] [Full Text] [Related]
47. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
48. An early clinical and toxicity trial of EX 11-582A in chronic schizophrenia. Simpson GM; Zoubok B; Lee JH Curr Ther Res Clin Exp; 1976 Jan; 19(1):87-98. PubMed ID: 812669 [No Abstract] [Full Text] [Related]
49. [Activity profile of carpipramine. Results of an open trial and a double-blind trial versus doxepin]. Woggon B; Angst J Arzneimittelforschung; 1976; 26(12):2226-30. PubMed ID: 14652 [TBL] [Abstract][Full Text] [Related]
50. [Double-blind clinical study of carpipramine/placebo (author's transl)]. Eckmann F Arzneimittelforschung; 1976; 26(12):2224-6. PubMed ID: 14651 [TBL] [Abstract][Full Text] [Related]
51. [Studies on cardio-circulatory effects of carpipramine. Results of a double-blind study (author's transl)]. Eckmann F; Sommer J; Trummer W Arzneimittelforschung; 1977; 27(1):148-52. PubMed ID: 322672 [TBL] [Abstract][Full Text] [Related]
52. [Preliminary trials of carpipramine, a compound related to antidepressive neuroleptic agents]. Deniker P; Peron-Magnan P; Ginestet D; Loo H; Colonna L Therapie; 1972; 27(1):177-81. PubMed ID: 5017553 [No Abstract] [Full Text] [Related]
53. [Clinical effects of moderate and high doses of carpipramine (author's transl)]. Athen D; Bente D; Bikadorow V; Feder J; Müller-Oerlinghausen B Pharmakopsychiatr Neuropsychopharmakol; 1975 Sep; 8(5):269-309. PubMed ID: 1233521 [TBL] [Abstract][Full Text] [Related]
54. [Pharmacological treatment of delusional depression]. Amore M; Giordani L; Giorgetti G; Zazzeri N Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200 [TBL] [Abstract][Full Text] [Related]